ANTIBODIES CONJUGATED OR FUSED TO THE RECEPTOR-BINDING DOMAIN OF THE SARS-COV-2 SPIKE… Application WO-2022101302-A1 World Intellectual Property Organisation (WIPO) 19 May 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086364-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086365-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
VIRAL VACCINE VECTOR FOR IMMUNIZATION AGAINST A BETACORONAVIRUS Application WO-2021233989-A1 World Intellectual Property Organisation (WIPO) 25 Nov 2021
NUCLEIC ACID VACCINES FOR CORONAVIRUS Application WO-2021204179-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
USE OF ANTI-IL-6 ANTIBODY, E.G., CLAZAKIZUMAB FOR TREATMENT/PREVENTION OF ARDS ASSOCIATED… Application WO-2021188727-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021